2‐Carboranylquinazoline: The Path to an ABCG2 Inhibitor
ChemMedChem · 2023
DOI: 10.1002/cmdc.202300094 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Philipp Stockmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Inorganic Chemistry Faculty of Chemistry and Mineralogy, Universität Leipzig, Johannisallee 29, 04103, Leipzig, Germany. Hauptthemen laut MEDLINE: Neoplasm Proteins, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The role of ATP‐binding cassette (ABC) transporter‐mediated multidrug resistance (MDR) in anti‐cancer therapy is often challenging, frequently leading to inefficiency of treatments. Cancer cells exploit efflux transporters, like the breast cancer resistance protein (BCRP, ABCG2), to secrete chemotherapeutic substances. In this study, an N ‐phenyl‐2‐carboranylquinazolin‐4‐amine ( 8 ) was designed as inorganic‐organic hybrid BCRP inhibitor. In particular, the ABCG2‐transporter inhibitor‐prominent scaffold N ‐phenylquinazolin‐4‐amine was combined with a boron−carbon cluster (carborane) moiety. Introducing a carborane at 2‐position of the quinazoline scaffold resulted in an increased inhibitory activity towards human ABCG2 (hABCG2) compared to its recently published regioisomer N ‐carboranyl‐2‐phenyl‐quinazolin‐4‐amine. The carboranylquinazoline 8 further showed the ability to reverse hABCG2‐mediated drug resistance in MDCKII‐hABCG2 cells by lowering the IC 50 value of the BCRP‐substrate mitoxantrone, similar to the standard reference and strong inhibitor Ko143, without exhibiting intrinsic toxicity in the lower micromolar ranges. These results make compound 8 a promising scaffold for the design of further BCRP inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Inorganic Chemistry Faculty of Chemistry and Mineralogy, Universität Leipzig, Johannisallee 29, 04103, Leipzig, Germany.
- Institute of Pharmacology Pharmacy and Toxicology Faculty of Veterinary Medicine, Universität Leipzig, An den Tierkliniken 15, 04103, Leipzig, Germany.
ORCID-Profile: Philipp Stockmann, Lydia Kuhnert, Walther Honscha, Evamarie Hey-Hawkins
Zitieren
APA
Stockmann, P., Kuhnert, L., Zörner, L., Honscha, W., & Hey-Hawkins, E. (2023). 2‐Carboranylquinazoline: The Path to an ABCG2 Inhibitor. ChemMedChem. https://doi.org/10.1002/cmdc.202300094
Vancouver
Stockmann P, Kuhnert L, Zörner L, Honscha W, Hey-Hawkins E. 2‐Carboranylquinazoline: The Path to an ABCG2 Inhibitor. ChemMedChem. 2023. doi:10.1002/cmdc.202300094
BibTeX
@article{Stockmann2023,
author = {Stockmann, Philipp and Kuhnert, Lydia and Zörner, Lisa and Honscha, Walther and Hey-Hawkins, Evamarie},
title = {2‐Carboranylquinazoline: The Path to an ABCG2 Inhibitor},
journal = {ChemMedChem},
year = {2023},
doi = {10.1002/cmdc.202300094}
}
EUVIMED